PUVA lentigines.
Farr PM, Diffey BL.
Photodermatol. 1987 Feb;4(1):59.
PUVA--lentigo.
Kanerva L, Lauharanta J.
Photodermatol. 1985 Apr;2(2):49-51.
PUVA lentigines confined to mycosis fungoides lesions.
Gonzàlez-de Arriba A, Pedraz J, Jones-Caballero M, Nam-Cha T, Fernández-Herrera J, García-Diez A.
J Eur Acad Dermatol Venereol. 2007 Aug;21(7):1005-6. doi: 10.1111/j.1468-3083.2006.02078.x.
Morphologic alterations of epidermal melanocytes and melanosomes in PUVA lentigines: a comparative ultrastructural investigation of lentigines induced by PUVA and sunlight.
Nakagawa H, Rhodes AR, Momtaz-T K, Fitzpatrick TB.
J Invest Dermatol. 1984 Jan;82(1):101-7. doi: 10.1111/1523-1747.ep12259212.
PUVA-induced melanocytic atypia: is it confined to PUVA lentigines?
Abel EA, Reid H, Wood C, Hu CH.
J Am Acad Dermatol. 1985 Nov;13(5 Pt 1):761-8. doi: 10.1016/s0190-9622(85)70219-8.
Cryotherapy of PUVA lentigines.
Leroy D, Dompmartin A, Dubreuil A, Louvet S.
Br J Dermatol. 1996 Dec;135(6):988-90. doi: 10.1046/j.1365-2133.1996.d01-1108.x.
Cutaneous carcinoma and PUVA lentigines in Thai patients treated with oral PUVA.
Gritiyarangsan P, Sindhavananda J, Rungrairatanaroj P, Kullavanijaya P.
Photodermatol Photoimmunol Photomed. 1995 Aug;11(4):174-7. doi: 10.1111/j.1600-0781.1995.tb00162.x.
T1799A BRAF mutation is common in PUVA lentigines.
Lassacher A, Worda M, Kaddu S, Heitzer E, Legat F, Massone C, Cerroni L, Kerl H, Ananthaswamy HN, Wolf P.
J Invest Dermatol. 2006 Aug;126(8):1915-7. doi: 10.1038/sj.jid.5700250. Epub 2006 Mar 23.
Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
Takashima A, Matsunami E, Yamamoto K, Kitajima S, Mizuno N.
Photodermatol Photoimmunol Photomed. 1990 Oct;7(5):218-21.
The PUVA lentigo: an analysis of predisposing factors.
Rhodes AR, Stern RS, Melski JW.
J Invest Dermatol. 1983 Nov;81(5):459-63. doi: 10.1111/1523-1747.ep12522663.
